# A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants

> **NCT02406261** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 82 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lanabecestat
- **DRUG:** Simvastatin
- **DRUG:** Midazolam
- **DRUG:** Midazolam
- **DRUG:** Donepezil
- **DRUG:** Lanabecestat

## Key facts

- **NCT ID:** NCT02406261
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-30
- **Primary completion:** 2015-08-31
- **Final completion:** 2015-08-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406261, "A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02406261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*